Cefazaflur sodium
- Level
- Commodity
- Parent
- 51282500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51282529This classification denotes the sodium form of a cephalosporin antibiotic with the molecular structure C13H13F3N6O4S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 97I0692RNT chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-7-((((trifluoromethyl)thio)acetyl)amino)-, (6r-trans)-, but more commonly known as cefazaflur, which bears US NIH Compound Identifier 40239. European Medicines Agency schedules Cefazaflur in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07377MIG. The term CEFAZAFLUR is an International Non-Proprietary Name or INN. Most nations, for tariff and trade purposes, schedule cefazaflur sodium under HS 29419000 and SITC 54139. As of Q4 2014, CEFAZAFLUR SODIUM remains US FDA's Preferred Term for this commodity. Cefazaflur sodium bears US NLM identifiers UMLS ID C2825417 and NCI Concept Code C81028. SMILES: CN1C(NNN1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CSC(F)(F)F)SC2)C(=O)[O-].[NA+].
Same parent
Under 51282500 · 31Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.